1. Home
  2. BHST vs JHS Comparison

BHST vs JHS Comparison

Compare BHST & JHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioHarvest Sciences Inc.

BHST

BioHarvest Sciences Inc.

HOLD

Current Price

$5.77

Market Cap

117.2M

Sector

N/A

ML Signal

HOLD

Logo John Hancock Income Securities Trust

JHS

John Hancock Income Securities Trust

HOLD

Current Price

$11.72

Market Cap

137.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHST
JHS
Founded
2007
1973
Country
Canada
United States
Employees
N/A
N/A
Industry
Finance Companies
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
117.2M
137.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BHST
JHS
Price
$5.77
$11.72
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$14.00
N/A
AVG Volume (30 Days)
37.2K
32.8K
Earning Date
11-13-2025
01-01-0001
Dividend Yield
N/A
3.96%
EPS Growth
N/A
N/A
EPS
N/A
0.02
Revenue
$32,720,000.00
N/A
Revenue This Year
$116.40
N/A
Revenue Next Year
$55.91
N/A
P/E Ratio
N/A
$553.50
Revenue Growth
45.88
N/A
52 Week Low
$4.72
$9.76
52 Week High
$12.80
$11.25

Technical Indicators

Market Signals
Indicator
BHST
JHS
Relative Strength Index (RSI) 55.59 51.90
Support Level $4.80 $11.75
Resistance Level $5.45 $11.86
Average True Range (ATR) 0.41 0.09
MACD 0.11 0.01
Stochastic Oscillator 71.86 39.02

Price Performance

Historical Comparison
BHST
JHS

About BHST BioHarvest Sciences Inc.

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

About JHS John Hancock Income Securities Trust

John Hancock Income Securities Trust is a United States-based closed-end diversified management investment company. Its main objective is to generate a high level of current income consistent with prudent investment risk. The fund invests its net assets (plus borrowings for investment purposes) in income securities, consisting of marketable corporate debt securities, governmental obligations, and cash and commercial paper. A majority of its net assets are invested in debt securities that are rated, at the time of acquisition, investment-grade or in unrated securities determined by the Fund's investment advisor or subadvisor to be of comparable credit quality.

Share on Social Networks: